Chemotherapy (platinum-based regimen)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Chemotherapy (platinum-based regimen), covering 2026-01-22 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004) [Phase 3]